The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin

Gianpaolo Papaccio, Michael Latronico, Gabriella Chieffi Baccari

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Diabetes mellitus was induced in 40 male C57BL6 mice by injection of a low dose of streptozocin (45 mg/kg body weight) on 5 consecutive days. Twenty four of the mice were immunosuppressed by administration of 1.5 mg FK506/kg body weight daily for 10, 15, 18 and 24 days. Administration of FK506 almost completely inhibited the streptozocin-induced islet damage, and consequently glycaemia remained normal. In FK506-treated animals any inflammatory infiltrate was very sparse and was limited to the vascular pole of the islets. Immunocytochemical results demonstrated that infiltrating cells were Ia-immunoreactive, but were not activated. Ultrastructural observations confirmed the absence of B cell necrosis and degranulation in FK506-treated mice; the few infiltrating elements encountered did not contain phagocytic vesicles or show other signs of activation.

Original languageEnglish
Pages (from-to)573-578
Number of pages6
JournalCell & Tissue Research
Volume277
Issue number3
DOIs
Publication statusPublished - Sep 1994

Fingerprint

Tacrolimus
Immunosuppressive Agents
Streptozocin
Islets of Langerhans
Body Weight
Cell Degranulation
Medical problems
Blood Vessels
Poles
Diabetes Mellitus
Animals
B-Lymphocytes
Necrosis
Chemical activation
Cells
Injections

Keywords

  • B cell
  • FK506
  • Immunosuppression
  • Mouse C57BL6
  • Pancreatic islet
  • Streptozocin
  • Type 1 diabetes

ASJC Scopus subject areas

  • Anatomy
  • Clinical Biochemistry
  • Cell Biology

Cite this

The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin. / Papaccio, Gianpaolo; Latronico, Michael; Baccari, Gabriella Chieffi.

In: Cell & Tissue Research, Vol. 277, No. 3, 09.1994, p. 573-578.

Research output: Contribution to journalArticle

@article{c2a4db3e22da4d5583bb618715cff7ce,
title = "The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin",
abstract = "Diabetes mellitus was induced in 40 male C57BL6 mice by injection of a low dose of streptozocin (45 mg/kg body weight) on 5 consecutive days. Twenty four of the mice were immunosuppressed by administration of 1.5 mg FK506/kg body weight daily for 10, 15, 18 and 24 days. Administration of FK506 almost completely inhibited the streptozocin-induced islet damage, and consequently glycaemia remained normal. In FK506-treated animals any inflammatory infiltrate was very sparse and was limited to the vascular pole of the islets. Immunocytochemical results demonstrated that infiltrating cells were Ia-immunoreactive, but were not activated. Ultrastructural observations confirmed the absence of B cell necrosis and degranulation in FK506-treated mice; the few infiltrating elements encountered did not contain phagocytic vesicles or show other signs of activation.",
keywords = "B cell, FK506, Immunosuppression, Mouse C57BL6, Pancreatic islet, Streptozocin, Type 1 diabetes",
author = "Gianpaolo Papaccio and Michael Latronico and Baccari, {Gabriella Chieffi}",
year = "1994",
month = "9",
doi = "10.1007/BF00300231",
language = "English",
volume = "277",
pages = "573--578",
journal = "Cell and Tissue Research",
issn = "0302-766X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - The immunosuppressant FK506 inhibits the damage to mouse pancreatic islets induced by low dose streptozocin

AU - Papaccio, Gianpaolo

AU - Latronico, Michael

AU - Baccari, Gabriella Chieffi

PY - 1994/9

Y1 - 1994/9

N2 - Diabetes mellitus was induced in 40 male C57BL6 mice by injection of a low dose of streptozocin (45 mg/kg body weight) on 5 consecutive days. Twenty four of the mice were immunosuppressed by administration of 1.5 mg FK506/kg body weight daily for 10, 15, 18 and 24 days. Administration of FK506 almost completely inhibited the streptozocin-induced islet damage, and consequently glycaemia remained normal. In FK506-treated animals any inflammatory infiltrate was very sparse and was limited to the vascular pole of the islets. Immunocytochemical results demonstrated that infiltrating cells were Ia-immunoreactive, but were not activated. Ultrastructural observations confirmed the absence of B cell necrosis and degranulation in FK506-treated mice; the few infiltrating elements encountered did not contain phagocytic vesicles or show other signs of activation.

AB - Diabetes mellitus was induced in 40 male C57BL6 mice by injection of a low dose of streptozocin (45 mg/kg body weight) on 5 consecutive days. Twenty four of the mice were immunosuppressed by administration of 1.5 mg FK506/kg body weight daily for 10, 15, 18 and 24 days. Administration of FK506 almost completely inhibited the streptozocin-induced islet damage, and consequently glycaemia remained normal. In FK506-treated animals any inflammatory infiltrate was very sparse and was limited to the vascular pole of the islets. Immunocytochemical results demonstrated that infiltrating cells were Ia-immunoreactive, but were not activated. Ultrastructural observations confirmed the absence of B cell necrosis and degranulation in FK506-treated mice; the few infiltrating elements encountered did not contain phagocytic vesicles or show other signs of activation.

KW - B cell

KW - FK506

KW - Immunosuppression

KW - Mouse C57BL6

KW - Pancreatic islet

KW - Streptozocin

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=0028071193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028071193&partnerID=8YFLogxK

U2 - 10.1007/BF00300231

DO - 10.1007/BF00300231

M3 - Article

C2 - 7525068

AN - SCOPUS:0028071193

VL - 277

SP - 573

EP - 578

JO - Cell and Tissue Research

JF - Cell and Tissue Research

SN - 0302-766X

IS - 3

ER -